In Alzheimer's disease and related dementias, cognitive decline is driven by the over-accumulation of a normal brain protein known as tau. Wherever tau builds up, nearby brain tissue starts to degenerate and die.
Nov 22, 2023
0
92
Cleveland Clinic researchers analyzed genes and brain tissue of patients with Alzheimer's and found that differences in brain immunometabolism—the interactions between the immune system and the ways cells create energy—may ...
Nov 21, 2023
0
0
A Saint Louis University researcher was instrumental in developing the first and only Food and Drug Administration (FDA) approved treatment for agitation associated with Alzheimer's dementia.
Nov 21, 2023
0
48
Two stories dominated Alzheimer's news this year: The FDA's approval of Leqembi, the first drug to slow progression of the disease, and a surprising study showing that mild cognitive impairment is wildly underdiagnosed.
Nov 20, 2023
0
0
A five-year, £5 million initiative has just been launched to investigate the feasibility of using new blood tests in the diagnosis of Alzheimer's disease. Alzheimer's Research UK and the Alzheimer's Society are working with ...
Nov 20, 2023
0
0
Alzheimer's disease (AD), the most prevalent neurodegenerative disease globally, poses a significant threat to human health. Most AD patients are diagnosed after the age of 65, categorized as late-onset AD (LOAD). However, ...
Nov 17, 2023
0
2
Alzheimer's disease is feared by many―and for good reason. The brain disorder slowly destroys memory along with a person's ability to reason, speak, carry out daily tasks and recognize loved ones. To date, there's no cure. ...
Nov 16, 2023
0
2
A rare but potent genetic mutation that alters a protein in the brain's immune cells, known as microglia, can give people as much as a three-fold greater risk of developing Alzheimer's disease. A new study by researchers ...
Nov 16, 2023
0
59
A new research paper titled "Longitudinal characterization of behavioral, morphological and transcriptomic changes in a tauopathy mouse model" has been published in Aging.
Nov 15, 2023
0
0
With the rise of new drugs that can target the amyloid-beta plaques in the brain that are an early sign of Alzheimer's disease, new ways are needed to determine whether memory loss and thinking problems are due to Alzheimer's ...
Nov 15, 2023
0
0
